Home/Pipeline/Inspexion™ Pharmacogenomic Testing

Inspexion™ Pharmacogenomic Testing

Drug Response & Metabolism

CommercialActive

Key Facts

Indication
Drug Response & Metabolism
Phase
Commercial
Status
Active
Company

About Kailos Genetics

Kailos Genetics is a private, commercial-stage diagnostics company enabling precision medicine through integrated genetic testing services and reagent products. Its core business is built on a dual model: offering direct-to-provider clinical tests like Expedio™ for hereditary cancer and Inspexion™ for pharmacogenomics, while also supplying clinical-grade NGS reagents and bioinformatics software to research labs via its Kailos Complete™ and Kailos Flex™ programs. The company's strategy centers on making advanced genetic analysis more accessible and customizable for both clinical and research settings, positioning itself in the growing markets of preventive oncology and personalized drug therapy.

View full company profile

Therapeutic Areas

Other Drug Response & Metabolism Drugs

DrugCompanyPhase
Pharmacogenomics TestGenematrixCommercial